{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:57:45Z","timestamp":1779926265788,"version":"3.53.1"},"reference-count":17,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2014,4,16]]},"abstract":"<jats:p>With the introduction of potent immunosuppressive and chemotherapeutic medications for various diseases, there is an increased incidence of therapy-related myeloid neoplasms. They are the result of mutational rearrangement and historically, have a grave prognosis compared with de novo myeloid neoplasms. We did a short review on various types of myeloid leukaemias reported after therapy with antitumour necrosis factor and also report, to the best of our knowledge, one among the very few cases of therapy-related acute promyelocytic leukaemia in a patient on infliximab therapy for refractory Crohn's disease. The patient responded well to the traditional treatment and is in complete remission for more than 5\u2005years.<\/jats:p>","DOI":"10.1136\/bcr-2013-203318","type":"journal-article","created":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T12:55:33Z","timestamp":1400504133000},"page":"bcr2013203318","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Acute promyelocytic leukaemia (APL) in a patient with Crohn's disease and exposure to infliximab: a rare clinical presentation and review of the literature"],"prefix":"10.1136","volume":"2014","author":[{"given":"Farhan","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhirami","family":"Vivekanandarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Housam","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Shutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T","family":"Hurford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,5,19]]},"reference":[{"key":"2025042705122228000_2014.may19_1.bcr2013203318.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3343"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.3","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-199905000-00008"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.075937"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.5","doi-asserted-by":"publisher","DOI":"10.1002\/art.10679"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.6","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.051771"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.7","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.760"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604935"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.9","doi-asserted-by":"publisher","DOI":"10.1007\/BF01300254"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(03)01715-5"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.11","first-page":"999","article-title":"Acute myeloid leukemia after infliximab: a case report","volume":"27","author":"Kemta Lekpa","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg128"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.06.032"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20926"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.15","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e318188950a"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.16","doi-asserted-by":"publisher","DOI":"10.4078\/jrd.2012.19.2.91"},{"key":"2025042705122228000_2014.may19_1.bcr2013203318.17","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12189"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-203318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T12:12:27Z","timestamp":1745755947000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-203318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,19]]},"references-count":17,"alternative-id":["10.1136\/bcr-2013-203318"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-203318","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,19]]}}}